Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS026799-08
Application #
2266112
Study Section
Neurology C Study Section (NEUC)
Project Start
1988-12-01
Project End
1998-11-30
Budget Start
1995-12-07
Budget End
1996-11-30
Support Year
8
Fiscal Year
1996
Total Cost
Indirect Cost

  Institution

Name
University of California San Francisco
Department
Neurology
Type
Schools of Medicine
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143

  Publications

Bove, Riley; Chitnis, Tanuja; Cree, Bruce Ac et al. (2018) SUMMIT (Serially Unified Multicenter Multiple Sclerosis Investigation): creating a repository of deeply phenotyped contemporary multiple sclerosis cohorts. Mult Scler 24:1485-1498
Mack, Steven J; Udell, Julia; Cohen, Franziska et al. (2018) High resolution HLA analysis reveals independent class I haplotypes and amino-acid motifs protective for multiple sclerosis. Genes Immun :
Jia, Xiaoming; Madireddy, Lohith; Caillier, Stacy et al. (2018) Genome sequencing uncovers phenocopies in primary progressive multiple sclerosis. Ann Neurol 84:51-63
Graves, Jennifer S; Henry, Roland G; Cree, Bruce A C et al. (2018) Ovarian aging is associated with gray matter volume and disability in women with MS. Neurology 90:e254-e260
Azevedo, Christina J; Cen, Steven Y; Khadka, Sankalpa et al. (2018) Thalamic atrophy in multiple sclerosis: A magnetic resonance imaging marker of neurodegeneration throughout disease. Ann Neurol 83:223-234
Canto, Ester; Isobe, Noriko; Didonna, Alessandro et al. (2018) Aberrant STAT phosphorylation signaling in peripheral blood mononuclear cells from multiple sclerosis patients. J Neuroinflammation 15:72
Greenfield, Ariele L; Hauser, Stephen L (2018) B-cell Therapy for Multiple Sclerosis: Entering an era. Ann Neurol 83:13-26
Creary, Lisa E; Mallempati, Kalyan C; Gangavarapu, Sridevi et al. (2018) Deconstruction of HLA-DRB1*04:01:01 and HLA-DRB1*15:01:01 class II haplotypes using next-generation sequencing in European-Americans with multiple sclerosis. Mult Scler :1352458518770019
International Multiple Sclerosis Genetics Consortium. Electronic address: chris.cotsapas@yale.edu; International Multiple Sclerosis Genetics Consortium (2018) Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk. Cell 175:1679-1687.e7
Gelfand, Jeffrey M; Cree, Bruce A C; Hauser, Stephen L (2017) Ocrelizumab and Other CD20+ B-Cell-Depleting Therapies in Multiple Sclerosis. Neurotherapeutics 14:835-841

Showing the most recent 10 out of 92 publications